ClinConnect ClinConnect Logo
Search / Trial NCT06722092

VR and Scrip Training of PWA, Randomized Controlled Trial

Launched by THE HONG KONG POLYTECHNIC UNIVERSITY · Dec 5, 2024

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Functional Communication Randomized Controlled Trial Script Training Immersive Reality Aphasia Intervention

ClinConnect Summary

This clinical trial is studying new ways to help people who have trouble speaking after a stroke, a condition called aphasia. The researchers want to find out if using a computerized script training program can improve the ability of Cantonese-speaking individuals to communicate verbally and also enhance their nonverbal thinking skills. Additionally, they are exploring whether virtual reality (VR) can make these improvements even better.

To participate in this trial, people need to be between 30 and 80 years old, have had a stroke more than six months ago, and be fluent in Cantonese. They should not have other serious brain conditions or significant speech issues. If eligible, participants will engage in training sessions that may involve both script training and VR experiences. It's important to note that the trial is not yet recruiting participants, and those who experience problems like nausea or headaches with VR will not be able to join.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. a stroke onset more than six months, with an Aphasia Quotient (AQ) below 96.4, as evaluated by the Cantonese version of Western Aphasia Battery (CAB; Yiu, 1992),
  • 2. premorbid fluent Cantonese speakers,
  • 3. aged between 30 and 80 years,
  • 4. no reported progressive neurogenic disorders such as dementia or Parkinson's disease,
  • 5. no motor speech disorders of moderate to severe level, and
  • 6. normal or corrected-to-normal vision and hearing functions
  • Exclusion Criteria:
  • 1. concurrent participation in other aphasia treatment trials, and
  • 2. incompatibility with immersive VR exposure such as complains of nausea, headache, or other severe discomforts during trial use of a head-mounted device during screening.

About The Hong Kong Polytechnic University

The Hong Kong Polytechnic University (PolyU) is a leading institution in applied research and education, dedicated to advancing knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, PolyU focuses on conducting rigorous and ethically sound research to enhance understanding of medical interventions and improve patient outcomes. The university leverages its multidisciplinary expertise, state-of-the-art facilities, and collaboration with industry partners to facilitate groundbreaking studies that address pressing health challenges. Committed to fostering an environment of academic excellence, PolyU aims to translate research findings into practical solutions that benefit society and contribute to the global advancement of healthcare.

Locations

Patients applied

0 patients applied

Trial Officials

Winsy WS Wong, PhD

Principal Investigator

Hong Kong Polytechnic University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported